FAVOURABLE OUTCOME IN A PATIENT BITTEN BY A RABID BAT INFECTED WITH THE EUROPEAN BAT LYSSAVIRUS-1
暂无分享,去创建一个
S. Roels | B. Brochier | S. Van Gucht | R. Vanhoof | V. Suin | S. Gucht | J. Vanderpas | A. Francart | R. Verlinde | J. Colyn | Bernard Brochier | Raymond Vanhoof | Stefan Roels
[1] F. Nazé,et al. A non-invasive intranasal inoculation technique using isoflurane anesthesia to infect the brain of mice with rabies virus. , 2011, Journal of virological methods.
[2] P. Galle,et al. Management and outcomes after multiple corneal and solid organ transplantations from a donor infected with rabies virus. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[3] T. Selhorst,et al. Antibodies induced by vaccination with purified chick embryo cell culture vaccine (PCECV) cross-neutralize non-classical bat lyssavirus strains. , 2009, Vaccine.
[4] K. Takumi,et al. Public health risk analysis of European bat lyssavirus infection in The Netherlands , 2008, Epidemiology and Infection.
[5] K. Takumi,et al. European Bat Lyssaviruses, the Netherlands , 2005, Emerging infectious diseases.
[6] N. Johnson,et al. Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses. , 2005, Vaccine.
[7] C. Rupprecht,et al. Survival after treatment of rabies with induction of coma. , 2005, The New England journal of medicine.
[8] N. Johnson,et al. European bat lyssaviruses: an emerging zoonosis , 2003, Epidemiology and Infection.
[9] C. Rupprecht,et al. Emerging epidemiology of bat-associated cryptic cases of rabies in humans in the United States. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] N. Tordo,et al. Evidence of Two Lyssavirus Phylogroups with Distinct Pathogenicity and Immunogenicity , 2001, Journal of Virology.
[11] C. Rupprecht,et al. Use of mouse anti-rabies monoclonal antibodies in postexposure treatment of rabies. , 1989, The Journal of clinical investigation.
[12] C. Wirblich,et al. The cell biology of rabies virus: using stealth to reach the brain , 2010, Nature Reviews Microbiology.
[13] Nicholas Johnson,et al. Towards the elimination of rabies in Eurasia. , 2008, Developments in biologicals.
[14] I. L. Roux,et al. Rabies control in Belgium: from eradication in foxes to import of a contaminated dog Rabiësbestrijding in België: van het uitroeien bij vossen tot de invoer van een besmette hond , 2008 .
[15] T. Selhorst,et al. Cross reactive antigenicity in orally vaccinated foxes and raccoon dogs against European Bat Lyssavirus type 1 and 2. , 2006, Developments in biologicals.
[16] A. Fooks,et al. Ability of rabies vaccine strains to elicit cross-neutralising antibodies. , 2006, Developments in biologicals.
[17] G. Garnett,et al. ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES , 2006 .
[18] H. Chesson,et al. ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES , 2006 .
[19] Bob Vandendriessche,et al. Zoogdieren in Vlaanderen : ecologie en verspreiding van 1987 tot 2002 , 2003 .
[20] C. Rupprecht,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Vector Transmission Review Rabies Mechanisms and Diagnostic Challenges Human Rabies: a Disease of Complex Neuropathogenetic Mechanisms and Diagnostic Challenges , 2022 .